News
IRADIMED CORPORATION to Hold 2017 First Quarter Financial Results Conference Call on April 28th
WINTER SPRINGS, Fla., April 20, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 first quarter financial results before the market opens on Friday, April 28th. IRADIMED management will host a conference call the same...
IRADIMED Names John McCreery Chief Operating Officer
WINTER SPRINGS, Fla., March 30, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John McCreery has been appointed Chief Operating Officer, a new position within the Company. Mr. McCreery will have primary responsibility over the regulatory,...
IRADIMED CORPORATION to Present at 29th Annual Roth Conference
WINTER SPRINGS, Fla., March 01, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the 29th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi...
IRADIMED CORPORATION Announces Fourth Quarter 2016 Financial Results
Reports fourth quarter 2016 revenue of $6.0 millionReports fourth quarter 2016 GAAP diluted EPS of $0.10 and non-GAAP diluted EPS of $0.11 WINTER SPRINGS, Fla., Feb. 06, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous...
IRADIMED CORPORATION to Hold 2016 Fourth Quarter Financial Results Conference Call on February 6th
WINTER SPRINGS, Fla., Jan. 25, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 fourth quarter financial results before the market opens on Monday, February 6th. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION Announces 2017 Annual and First Quarter Financial Guidance
Announces Preliminary Full Year and Fourth Quarter 2016 RevenueAnnounces Fourth Quarter 2016 Financial Results Conference Call DateWINTER SPRINGS, Fla., Jan. 18, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV)...
IRADIMED CORPORATION Announces First Shipments of Its MRI Compatible Patient Vital Signs Monitor
WINTER SPRINGS, Fla., Jan. 03, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the first shipments of its MRI compatible patient vital signs monitoring system to international customers. "Shipments of the new 3880 MRI compatible patient vital signs...
IRADIMED CORPORATION Receives FDA Clearance for MRI Compatible IV Infusion Pump
WINTER SPRINGS, Fla., Dec. 19, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that it received U.S. Food and Drug Administration ("FDA") 510(k) clearance for its MRidium 3860+ magnetic resonance imaging ("MRI") compatible IV infusion pump system,...
IRADIMED CORPORATION Announces Third Quarter 2016 Financial Results
Reports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14 WINTER SPRINGS, Fla., Oct. 28, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV)...
IRADIMED CORPORATION to Hold 2016 Third Quarter Financial Results Conference Call on October 28th
WINTER SPRINGS, Fla., Oct. 18, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 third quarter financial results before the market opens on Friday, October 28th. IRADIMED management will host a conference call the same...